Skip to main content
. 2020 Nov 3;47(4):516–521. doi: 10.1097/DSS.0000000000002864

Figure 1.

Figure 1.

(A–G) Photographs of glabellar lines at maximum frown at baseline (A) and at each of Day 2 (B), Day 7 (C), Day 30 (D), Day 90 (E), Day 120 (F), and Day 150 (G) after treatment with 20U PrabotulinumtoxinA in a 36-year-old female patient with skin of color. This representative patient with skin of color was assessed as having Fitzpatrick skin Type VI and moderate glabellar lines at maximum frown at baseline by investigator assessment.